HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gillette's sales reach $2.29 bil. in second quarter; European toiletries revenues up 10%.

This article was originally published in The Rose Sheet

Executive Summary

GILLETTE EUROPEAN TOILETRIES SALES UP 10% IN THE SECOND QUARTER on the strength of Satin Care women's shave preps and Gillette Series antiperspirants and deodorants, VP-Investor Relations Everett Howe reported in a July 17 conference call with securities analysts.. The "star performer" in the region, Satin Care, had a "tremendous impact" on Gillette's Western European retail market, the company said. In addition, Gillette noted the region's deodorant business is "stronger than ever," boosted by the Clear Gel technology used in Gillette Series Clear Stick antiperspirants. Overall toiletries sales for the North Atlantic group (Western Europe, Canada and the U.S.) slipped 3%, but profits jumped 66%.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004433

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel